Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CADPS anticorps (N-Term)

CADPS Reactivité: Humain, Souris, Rat WB, IHC (p), EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN499525
  • Antigène Voir toutes CADPS Anticorps
    CADPS (Ca++-Dependent Secretion Activator (CADPS))
    Épitope
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 13
    • 7
    • 7
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 13
    • 1
    Lapin
    Clonalité
    • 14
    Polyclonal
    Conjugué
    • 12
    • 1
    • 1
    Cet anticorp CADPS est non-conjugé
    Application
    • 10
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
    Specificité
    This antibody reacts to CAPS1.
    Purification
    Affinity chromatography purified via peptide column
    Immunogène
    CAPS1 antibody was raised against a 21 amino acid peptide near the amino terminus of the human CAPS1.
    Isotype
    IgG
    Top Product
    Discover our top product CADPS Anticorps primaire
  • Indications d'application
    ELISA. Western Blot: CAPS1 antibody can be used for detection of CAPS1 by Western blot at 0.25 -0.5 μg/mL. Immunohistochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Buffer
    PBS containing 0.02 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C.
  • Antigène
    CADPS (Ca++-Dependent Secretion Activator (CADPS))
    Autre désignation
    CADPS (CADPS Produits)
    Synonymes
    anticorps CADPS1, anticorps CAPS, anticorps CAPS1, anticorps Caps, anticorps Caps1, anticorps Caps2, anticorps AU067781, anticorps mKIAA1121, anticorps CADPS, anticorps cadps, anticorps MGC122552, anticorps CAPS-1, anticorps caps, anticorps caps1, anticorps si:busm1-1i3.1, anticorps si:busm1-6a2.7, anticorps si:dz6a2.7, anticorps calcium dependent secretion activator, anticorps Ca2+-dependent secretion activator, anticorps Ca2+-dependent activator protein for secretion b, anticorps Ca2+ dependent secretion activator, anticorps Ca2+ dependent secretion activator L homeolog, anticorps Ca2+-dependent activator protein for secretion a, anticorps CADPS, anticorps Cadps, anticorps cadpsb, anticorps cadps, anticorps cadps.L, anticorps cadpsa
    Sujet
    CAPS1 and its related protein CAPS2 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles, CAPS-deficienct neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. CAPS1 acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4,5-bisphosphate and is thought to be a specific regulator of large dense-core vesicle fusion. Numerous isoforms of CAPS1 are known to exist. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.Synonyms: CAPS, CAPS-1, CAPS1, Calcium-dependent activator protein for secretion 1, Calcium-dependent secretion activator 1, KIAA1121
    ID gène
    8618
    NCBI Accession
    NP_899631
    UniProt
    Q9ULU8
    Pathways
    Synaptic Vesicle Exocytosis
Vous êtes ici:
Support technique